Sarissa Capital Management LP

Sarissa Capital Management LP, una Sociedad Limitada de DE con 9 empleados, de los cuales 6 están en roles de asesoramiento, tiene un número desconocido de clientes. Su estado ante la SEC es Aprobado, con una fecha de registro del 10 de abril de 2013.

• ALEXANDER JOHN DENNER

  CHIEF EXECUTIVE OFFICER/CHIEF INVESTMENT OFFICER posee 75% o más

• MARK ANTHONY DIPAOLO

  CHIEF LEGAL OFFICER/GENERAL COUNSEL posee menos de 5%

• PATRICE EADON BONFIGLIO

  CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER posee menos de 5%

• SARISSA CAPITAL MANAGEMENT GP LLC

  GENERAL PARTNER posee menos de 5%

• ALEXANDER JOHN DENNER

  MANAGING MEMBER posee 75% o más

• DEUTSCHE BANK SECURITIES INC.
  Estados Unidos
• J.P. MORGAN CLEARING CORP.
  Estados Unidos
• MORGAN STANLEY & CO. LLC
  Estados Unidos
• MORGAN STANLEY PRIVATE BANK NATIONAL ASSOCIATION
  Estados Unidos

• Blue Harbour Group LP
• Renaissance Capital LLC
• PAW Capital Partners LP
• COOK Pine Capital LLC
• SILVER POINT SPECIALTY CREDIT FUND MANAGEMENT, LLC
• Greenwich Wealth Management LLC
• Aristeia Capital LLC
• Catherine Avery Investment Management LLC
• AXA Investment Managers Inc
• Prana Capital Management LP

• Sarissa Capital Management LP Q3 2022 vs. Q4 2022 13F Holdings Comparison: Winners and Losers in the Pharma and Biotech Sectors

• ALLERGAN PLC $174,545k
• MEDICINES CO $153,246k
• BIOGEN INC $150,378k
• IRONWOOD PHARMACEUCL $106,314k
• Innoviva Inc $90,883k
• INTERCEPT PHARMACEUTICALS $60,234k
• JAZZ PHARMA PLC $28,013k
• PUMA BIOTECHNOLOGY INC $18,010k
• MERSANA THERAPEUTICS INC $15,187k
• CYCLERION THERAPEUTI $2,862k